ICM-203

N/A

Report date: 2026/03/28 20:00:32

Base Information

Drug NameICM-203
Drug Alias NameRecombinant adeno-associated viral (AAV) vector that expresses a therapeutic gene（ICM Biotech）ICM-203ICM-203RICM-203O
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionHomeobox protein Nkx-3.2 gene transference
TargetsHomeobox protein Nkx-3.2
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesICM Biotech Australia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesICM Co LtdICM Biotech Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A